New York Cancer & Blood Specialists - Eastchester Cancer Center

Sorting 2 by

Accepting patients

KPG-818

Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects
Learn more
  • CELMoD
  • Phase 1

Accepting patients

CERVINO

A Phase 3, Multicenter, Randomized, Open Label Study of ABBV-383 Compared With Standard Available Therapies in Subjects With Relapsed or Refractory Multiple Myeloma (3L+ RRMM Monotherapy Study)
Learn more
  • Bispecific Antibody
  • BCMA
  • CD3
  • Randomization
  • Phase 3